LRP2 and neoplasm: There were significant differences in mutation frequencies among different tumor types, with the highest mutation rates of LRP2 in melanoma (28.18%), uterine carcinosarcoma (17.99%) and lung squamous cell carcinoma (16.32%) (Fig. 1A).